Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsyResearch in context
Rana Raoof,
Sebastian Bauer,
Hany El Naggar,
Niamh M.C. Connolly,
Gary P. Brennan,
Elizabeth Brindley,
Thomas Hill,
Hazel McArdle,
Elaine Spain,
Robert J. Forster,
Jochen H.M. Prehn,
Hajo Hamer,
Norman Delanty,
Felix Rosenow,
Catherine Mooney,
David C. Henshall
Affiliations
Rana Raoof
Department of Physiology & Medical Physics, RCSI, Dublin, Ireland; Department of Anatomy, Mosul Medical College, University of Mosul, Mosul, Iraq
Sebastian Bauer
Epilepsy Center Hessen, Department of Neurology, Philipps University Marburg, Marburg, Germany; Epilepsy Center Frankfurt Rhine-Main, Neurocenter, Goethe-University Frankfurt, Frankfurt a.m., Germany; Center for Personalized Translational Epilepsy Research (CePTER), Frankfurt/Main, Germany
Hany El Naggar
Department of Physiology & Medical Physics, RCSI, Dublin, Ireland; Beaumont Hospital, Beaumont Road, Dublin, Ireland
Niamh M.C. Connolly
Department of Physiology & Medical Physics, RCSI, Dublin, Ireland
Gary P. Brennan
Department of Physiology & Medical Physics, RCSI, Dublin, Ireland
Elizabeth Brindley
Department of Physiology & Medical Physics, RCSI, Dublin, Ireland
Thomas Hill
Department of Physiology & Medical Physics, RCSI, Dublin, Ireland
Hazel McArdle
School of Chemical Sciences, National Centre for Sensor Research, Dublin City University, Dublin, Ireland
Elaine Spain
School of Chemical Sciences, National Centre for Sensor Research, Dublin City University, Dublin, Ireland
Robert J. Forster
School of Chemical Sciences, National Centre for Sensor Research, Dublin City University, Dublin, Ireland; FutureNeuro Research Centre, RCSI, Dublin, Ireland
Jochen H.M. Prehn
Department of Physiology & Medical Physics, RCSI, Dublin, Ireland; FutureNeuro Research Centre, RCSI, Dublin, Ireland
Hajo Hamer
Epilepsy Centre, Department of Neurology, University of Erlangen, Erlangen, Germany
Norman Delanty
Beaumont Hospital, Beaumont Road, Dublin, Ireland; FutureNeuro Research Centre, RCSI, Dublin, Ireland; Department of Molecular & Cellular Therapeutics, RCSI, Dublin, Ireland
Felix Rosenow
Epilepsy Center Hessen, Department of Neurology, Philipps University Marburg, Marburg, Germany; Epilepsy Center Frankfurt Rhine-Main, Neurocenter, Goethe-University Frankfurt, Frankfurt a.m., Germany; Center for Personalized Translational Epilepsy Research (CePTER), Frankfurt/Main, Germany
Catherine Mooney
FutureNeuro Research Centre, RCSI, Dublin, Ireland; School of Computer Science, UCD, Dublin, Ireland
David C. Henshall
Department of Physiology & Medical Physics, RCSI, Dublin, Ireland; FutureNeuro Research Centre, RCSI, Dublin, Ireland; Corresponding author at: Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin D02 YN77, Ireland.
Background: There are no blood-based molecular biomarkers of temporal lobe epilepsy (TLE) to support clinical diagnosis. MicroRNAs are short noncoding RNAs with strong biomarker potential due to their cell-specific expression, mechanistic links to brain excitability, and stable detection in biofluids. Altered levels of circulating microRNAs have been reported in human epilepsy, but most studies collected samples from one clinical site, used a single profiling platform or conducted minimal validation. Method: Using a case-control design, we collected plasma samples from video-electroencephalogram-monitored adult TLE patients at epilepsy specialist centers in two countries, performed genome-wide PCR-based and RNA sequencing during the discovery phase and validated findings in a large (>250) cohort of samples that included patients with psychogenic non-epileptic seizures (PNES). Findings: After profiling and validation, we identified miR-27a-3p, miR-328-3p and miR-654-3p with biomarker potential. Plasma levels of these microRNAs were also changed in a mouse model of TLE but were not different to healthy controls in PNES patients. We determined copy number of the three microRNAs in plasma and demonstrate their rapid detection using an electrochemical RNA microfluidic disk as a prototype point-of-care device. Analysis of the microRNAs within the exosome-enriched fraction provided high diagnostic accuracy while Argonaute-bound miR-328-3p selectively increased in patient samples after seizures. In situ hybridization localized miR-27a-3p and miR-328-3p within neurons in human brain and bioinformatics predicted targets linked to growth factor signaling and apoptosis. Interpretation: This study demonstrates the biomarker potential of circulating microRNAs for epilepsy diagnosis and mechanistic links to underlying pathomechanisms. Keywords: Biofluids, Dissociative seizures, Temporal lobe epilepsy, Status epilepticus, Noncoding RNA, Serum